CLINICAL SIGNIFICANCE OF PROBENECID TEST
- 17 March 1973
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 301 (7803), 614-615
- https://doi.org/10.1016/s0140-6736(73)90770-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- THE PROBENECID TEST IN PARKINSON'S DISEASEThe Lancet, 1972
- Predictive Value of the Probenecid Test for the Effect of L-Dopa Therapy in Parkinson's DiseaseNature New Biology, 1972
- Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's diseaseNeurology, 1972
- PROBENECID TEST IN PARKINSON'S DISEASEThe Lancet, 1971
- PREDICTING RESPONSE TO LEVODOPAThe Lancet, 1971
- Rapid elevation of biogenic amine metabolites in human CSF following probenecidLife Sciences, 1970
- 5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with ProbenecidNature, 1970
- Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's DiseaseNature, 1968
- In Vivo Measurement of Brain Serotonin TurnoverPublished by Elsevier ,1968
- Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecidLife Sciences, 1966